Vendor, Solna, SWE
Scandinavian Biopharma Holding Ab
UEI ZKASUJ7ZZC98, CAGE AYBAN
1 award and $22,746,941 obligated between September 18, 2024 and June 5, 2026, 0% under full and open competition, against 1.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $22,746,941 |
How it wins
Awards by competition, set-aside and type.
| Not Competed | 1 |
| Definitive Contract | 1 |
Hear when Scandinavian Biopharma Holding Ab wins an award and when a contract it holds is about to end.Follow it
Contracts ending soon
None of Scandinavian Biopharma Holding Ab's contracts with a published end date ends in the next 19 months.
Competes with
Vendors selling research and development in biotechnology (except nanobiotechnology) to Defense Health Agency, by dollars.
| Knowesis, Inc.Fairfax, VA | $39,167,895 |
| Abss Solutions Inc.Upper Marlboro, MD | $19,647,316 |
| Irving Burton Associates, LLCFalls Church, VA | $7,415,388 |
| Metis FoundationSan Antonio, TX | $2,719,208 |
| Queen Mary University of LondonLondon | $2,335,313 |
| Genovac Antibody Discovery LLCFargo, ND | $121,025 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| W81XWH20C0137Definitive Contract, September 18, 2024, Not Competed, 1 offers | Army Med Res Acq ActivityDefense Health Agency | This Contract Is for the Development of an E. Coli Vaccine for FDA Approval.NAICS 541714, PSC Q517 | $22,746,941 |
- Product and service codes
- Q517 Pharmacy Services
- Transactions
- 7 across 1 awards